MODERNA INC SAYS ITS COVID-19 VACCINE 90% EFFECTIVE IN US TRIALS

Highlights

• The Phase 3 clinical trial which currently was ongoing in the US involved over 30,000 people

• Though the reason behind the efficacy number going down was not revealed by the company, it is being said that this might be because of the emergence of new COVID-19 variant

According to the announcement made US-based biotech company Moderna, the coronavirus vaccine developed by them is 90 percent ....